Structures by: Jednačak T.
Total: 9
Pyridoxal-isonicotinoyl-hydrazone (μU~eq~6-oxo) -dodecakis(μU~eq~2-oxo)-hexa(oxomolybdenum) acetone solvate (1/3)
C23H34Mo6N4O25
RSC Advances (2014)
a=10.5047(2)Å b=18.6297(3)Å c=10.7312(2)Å
α=90° β=109.882(2)° γ=90°
((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl) methylene)benzohydrazide
C15H15N3O3
RSC Advances (2014)
a=8.537(4)Å b=13.573(5)Å c=12.290(5)Å
α=90° β=90.66(4)° γ=90°
Methanol(pyridoxal-isonicotinoyl -hydrazone- N,O,O)-dioxa-molybdenum(VI)
C15H16MoN4O6
RSC Advances (2014)
a=7.700(6)Å b=8.392(5)Å c=13.071(7)Å
α=99.59(5)° β=99.50(6)° γ=93.09(6)°
Cis-(N-((3-oxy)-5-(hydroxymethyl)-2 -methylpyridin-4-yl)methylene)-4- hydroxylbenzhydrazonato-methanol- dioxo-molybdenum(VI) methanol solvate
C17H21MoN3O8
RSC Advances (2014)
a=7.8373(5)Å b=9.3588(4)Å c=13.025(3)Å
α=92.297(8)° β=103.058(5)° γ=95.262(5)°
Bis(cis-(NCsp^3^-((3-oxy)-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylene)benzhydrazonato-dioxo-molybdenum(VI)) (μU~eq~6-oxo)-dodecakis(μU~eq~2-oxo)-hexa(oxomolybdenum) acetonitrile solvate (1/2)
C17H17Mo4N4O14.5
RSC Advances (2014)
a=16.04016(12)Å b=16.04016(12)Å c=17.79763(16)Å
α=90° β=90° γ=120°
1,5-bis(salicylidene)carbohydrazide
C15H14N4O3
Crystal Growth & Design (2014) 14, 6 2900
a=10.5804(12)Å b=15.7399(18)Å c=9.0114(11)Å
α=90.00° β=97.649(11)° γ=90.00°
1,5-bis(salicylidene)carbohydrazide
C15H14N4O3
Crystal Growth & Design (2014) 14, 6 2900
a=9.4272(14)Å b=10.3890(15)Å c=14.370(3)Å
α=90.00° β=102.477(2)° γ=90.00°
1,5-bis(salicylidene)carbohydrazide monohydrate
C15H14N4O3,H2O
Crystal Growth & Design (2014) 14, 6 2900
a=4.5443(5)Å b=12.2026(15)Å c=27.359(4)Å
α=90.00° β=90.00° γ=90.00°
1,5-bis(salicylidene)carbohydrazide
C15H14N4O3
Crystal Growth & Design (2014) 14, 6 2900
a=14.5908(6)Å b=9.3764(4)Å c=10.3283(3)Å
α=90.00° β=90.00° γ=90.00°